Acid, basic, and neutral peptidases present different profiles in chromophobe renal cell carcinoma and in oncocytoma

American Journal of Physiology - Renal Physiology

Volumn 294, Issue 4, 2008, Pages

  Blanco, Lorena ^a   Larrinaga, Gorka ^a   Pérez, Itxaro ^a   López, José I ^a   Gil, Javier ^a   Agirregoitia, Ekaitz ^a   Varona, Adolfo ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Chromophobe carcinoma; Peptide signaling; Renal oncocytoma; Renal tumor behavior

Indexed keywords

ACID PEPTIDASE; BASIC PEPTIDASE; NEUTRAL PEPTIDASE; PEPTIDASE; UNCLASSIFIED DRUG; PEPTIDE HYDROLASE; PRIMER DNA;

ADULT; AGED; ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; ONCOCYTOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; CANCER STAGING; ENZYMOLOGY; GENE EXPRESSION PROFILING; GENETICS; KIDNEY TUMOR; KINETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; PH; POLYMERASE CHAIN REACTION;

ADENOMA, OXYPHILIC; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; DNA PRIMERS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; HYDROGEN-ION CONCENTRATION; KIDNEY NEOPLASMS; KINETICS; MALE; MIDDLE AGED; NEOPLASM STAGING; PEPTIDE HYDROLASES; POLYMERASE CHAIN REACTION;

EID: 44949168668     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00469.2007     Document Type: Article

References (37)

1. Abrahams NA, Tamboli P. Oncocytic renal neoplasms: diagnostic considerations. Clin Lab Med 25: 317-339, 2005.
2. Albinston AL, McDowall SG, Matsacos D, Sim P, Clune E, Mustafa T, Lee J, Mendelsohn FA, Simpson RJ, Connolly LM, Chai SY. Evidence that the angiotensin IV (AT4) receptor is the enzyme insulin regulated aminopeptidase. J Biol Chem 276: 48263-48266, 2001.
3. Amin MB, Tamboli P, Javidan J, Stricker H, de Peralta Venturina M, Deshpande A, Menon M. Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: an experience of 405 cases. Am J Surg Pathol 26: 281-291, 2002.
4. Antczak C, De Meester I, Bauvois B. Ectopeptidases in pathophysiology. Bioessays 23: 251-260, 2001.
5. Avery AK, Beckstead J, Renshaw AA, Corless CL. Use of antibodies to RCC and CD10 in the differential diagnosis of renal neoplasms. Am J Surg Pathol 24: 203-210, 2000.
6. Bank U, Krüger S, Langner J, Roessner A. Review: peptidases and peptidase inhibitors in the pathogenesis of diseases. Disturbances in the ubiquitin-mediated proteolytic system. Protease antiprotease imbalance in inflammatory reactions. Role of cathepsins in tumour progression. Adv Exp Med Biol 477: 349-378, 2000.
7. Bannasch P, Zerban H. Animal models and renal carcinogenesis. In: Tumors and Tumorlike Conditions of The Kidneys and Ureters, edited by Eble JN. New York: Churchill-Livingstone, 1990.
8. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 72: 248-254, 1976.
9. Cadel S, Piesse C, Gouzy-Darmon C, Cohen P, Foulon T. Arginyl aminopeptidase. In: Aminopeptidases in Biology and Disease, edited by Hooper NM and Lendeckel U. New York: Kluwer Academic/Plenum, 2004, p. 113-126.
10. Carl-McGrath S, Lendeckel U, Ebert M, Röcken C. Ectopeptidases in tumour biology: a review. Histol Histopathol 21: 1339-1353, 2006.
11. Carrera MP, Ramírez-Expósito MJ, Valenzuela MT, Dueñas B, García MJ, Mayas MD, Martínez-Martos JM. Renin-angiotensin system-regulating aminopeptidase activities are modified in the pineal gland of rats with breast cancer induced by N-methyl- nitrosourea. Cancer Invest 24: 149-153, 2006.
12. Cowburn AS, Sobolewski A, Reed BJ, Deighton J, Murray J, Cadwallader KA, Bradley JR, Chilvers ER. Aminopeptidase N (CD13) regulates tumor necrosis factor-alpha-induced apoptosis in human neutrophils. J Biol Chem 281: 12458-12467, 2006.
13. Crotty TB, Farrow GM, Lieber MM. Chromophobe cell renal carcinoma: clinicopathological features of 50 cases. J Urol 154: 964-967, 1995.
14. Curnis F, Sacchi A, Borgna L, Magni F, Gasparri A, Corti A. Enhancement of tumor necrosis factor alpha antitumor immunotherapeutic properties by targeted delivery to aminopeptidase N (CD13). Nat Biotechnol 18: 1185-1190, 2000.
15. Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 6: 655-663, 1982.
16. Fukasawa K, Fujii H, Saitoh Y, Koizumi K, Aozuka Y, Sekine K, Yamada M, Saiki I, Nishikawa K. Aminopeptidase N (APN/CD13) is selectively expressed in vascular endothelial cells and plays multiple roles in angiogenesis. Cancer Lett 243: 135-143, 2006.
17. Göhring B, Holzhausen HJ, Meye A, Heynemann H, Rebmann U, Langner J, Riemann D. Endopeptidase 24.11/CD10 is downregulated in renal cell cancer. Int J Mol Med 2: 409-414, 1998.
18. Ino K, Shibata K, Kajiyama H, Kikkawa F, Mizutani S. Regulatory role of membrane-bound peptidases in the progression of gynecologic malignancies. Biol Chem 358: 683-690, 2004.
19. Ino K, Uehara C, Kikkawa F, Kajiyama H, Shibata K, Suzuki T, Khin EE, Ito M, Takeuchi M, Itakura A, Mizutani S. Enhancement of aminopeptidase A expression during angiotensin II-induced choriocarcinoma cell proliferation through AT1 receptor involving protein kinase Cand mitogen-activated protein kinase-dependent signaling pathway. J Clin Endocrinol Metab 88: 3973-3982, 2003.
20. Ishii K, Usui S, Yamamoto H, Sugimura Y, Tatematsu M, Hirano K. Decreases of metallothionein and aminopeptidase N in renal cancer tissues. J Biochem (Tokyo) 129: 253-258, 2001.
21. Kehlen A, Göhring B, Langner J, Riemann D. Regulation of the expression of aminopeptidase A, aminopeptidase N/CD13 and dipeptidylpeptidase IV/CD26 in renal carcinoma cells and renal tubular epithelial cells by cytokines and cAMP-increasing mediators. Clin Exp Immunol 111: 435-441, 1998.
22. Kovacs G, Akhtar M, Beckwith BJ, Bugert P, Cooper CS, Delahunt B, Eble JN, Fleming S, Ljungberg B, Medeiros LJ, Moch H, Reuter VE, Ritz E, Roos G, Schmidt D, Srigley JR, Storkel S, van den Berg E, Zbar B. The Heidelberg classification of renal cell tumors. J Pathol 183: 131-133, 1997.
23. Luan Y, Xu W. The structure and main functions of aminopeptidase N. Curr Med Chem 14: 639-647, 2007.
24. Mantle D, Lauffart B, McDermott J, Gibson A. Characterization of aminopeptidases in human kidney soluble fraction. Clin Chim Acta 187: 105-113, 1990.
25. Marchiò S, Lahdenranta J, Schlingemann RO, Valdembri D, Wesseling P, Arap MA, Hajitou A, Ozawa MG, Trepel M, Giordano RJ, Nanus DM, Dijkman HB, Oosterwijk E, Sidman RL, Cooper MD, Bussolino F, Pasqualini R, Arap W. Aminopeptidase A is a functional target in angiogenic blood vessels. Cancer Cell 5: 151-162, 2004.
26. Morra MN, Das S. Renal oncocytoma: a review of histogenesis, histopathology, diagnosis and treatment. J Urol 150: 295-302, 1993.
27. Murphy WM, Grignon DJ, Perlman EJ. Tumors of the kidney, bladder, and related urinary structures. AFIP Atlas of Tumor Pathology 4th Series, Fascicle 1, American Registry of Pathology, Washington, DC, 2004; p. 101-240.
28. Nanus DM, Bogenrieder T, Papandreou CN, Finstad CL, Lee A, Vlamis V, Motzer RJ, Bander NH, Albino AP, Reuter VE. Aminopeptidase A expression and enzymatic activity in primary human renal cancers. Int J Oncol 13: 261-267, 1998.
29. Nanus DM. Of peptides and peptidases: the role of cell surface peptidases in cancer. Clin Cancer Res 9: 6307-6309, 2003.
30. Petrovic N, Schacke W, Shapiro LH. CD13/Aminopeptidase N in tumor growth and angiogenesis. In: Aminopeptidases in Biology and Disease, edited by Hooper NM and Lendeckel U. New York: Kluwer Academic/Plenum, 2004, p. 179-200.
31. Scornik OA, Botbol V. Effects on mammals of the aminopeptidase inhibitor bestatine. In: Aminopeptidases in Biology and Disease, edited by Hooper NM and Lendeckel U. New York: Kluwer Academic/Plenum, 2004, p. 127-143.
32. Sekine K, Fujii H, Abe F, Nishikawa K. Augmentation of dead ligand-induced apoptosis by aminopeptidase inhibitors in human solid tumor cell lines. Int J Cancer 94: 485-491, 2001.
33. th edition). New York: Wiley-Liss, 2002.
34. Stavropoulou V, Xie J, Henriksson M, Tomkinson B, Imreh S, Masucci MG. Mitotic infidelity and centrosome duplication errors in cells overexpressing tripeptidyl-peptidase II. Cancer Res 65: 1361-1368, 2005.
35. Suganuma T, Ino K, Shibata K, Nomura S, Kajiyama H, Kikkawa F, Tsuruoka N, Mizutani S. Regulation of aminopeptidase A expression in cervical carcinoma: role of tumor-stromal interaction and vascular endothelial growth factor. Lab Invest 84: 639-648, 2004.
36. Tieku S, Hooper NM. Inhibition of aminopeptidases N, A, and W. A re-evaluation of the actions of bestatin and inhibitors of angiotensin converting enzyme. Biochem Pharmacol 44: 1725-1730, 1992.
37. Varona A, Blanco L, López JI, Gil J, Agirregoitia E, Irazusta J, Larrinaga G. Altered levels of acid, basic, and neutral peptidase activity and expression in human clear cell renal cell carcinoma. Am J Physiol Renal Physiol 292: F780-F788, 2007.